B Gwen Windham1, Michael E Griswold2, Seth Lirette2, Anna Kucharska-Newton3, Randi E Foraker4, Wayne Rosamond5, Josef Coresh6, Stephen Kritchevsky7, Thomas H Mosley8. 1. Department of Medicine-Geriatrics and gwindham@umc.edu. 2. Center of Biostatistics, University of Mississippi Medical Center, Jackson. 3. Kucharska-Newton: Cardiovascular Disease Program, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. 4. Division of Epidemiology, The Ohio State University College of Public Health, Columbus. 5. Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis. 6. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 7. Sticht Center on Aging, Wake Forest School of Medicine, Winston-Salem, North Carolina. 8. Department of Medicine-Geriatrics and.
Abstract
BACKGROUND: Impaired functional status attenuates the relationship of systolic blood pressure (SBP) with mortality in older adults but has not been studied in middle-aged populations. METHOD: Among 10,264 stroke-free Atherosclerosis Risk in Communities participants (mean age 62.8 [5.7] years; 6,349 [62%] younger [<65 years]; 5,148 [50%] men; 2,664 [26%] Black), function was defined as good function (GF) for those self-reporting no difficulty performing functional tasks and basic or instrumental tasks of daily living; all others were defined as impaired function (IF). SBP categories were normal (<120 mmHg), prehypertension (120-139 mmHg), and hypertension (≥140 mmHg). Mortality risk associated with SBP was estimated using adjusted Cox proportional hazard models with a triple interaction between age, functional status, and SBP. RESULTS: Mean follow-up was 12.9 years with 2,863 (28%) deaths. Among younger participants, 3,017 (48%) had IF; 2,279 of 3,915 (58%) older participants had IF. Prehypertension (hazard ratio [HR] = 1.48 [1.03, 2.15] p = .04) and hypertension (HR = 1.97 [1.29, 3.03] p = .002) were associated with mortality in younger GF and older (≥65 years) GF participants (prehypertension HR = 1.21 [1.06, 1.37] p = .005; hypertension HR = 1.47 [1.36, 1.59] p < .001). Among IF participants, prehypertension was not associated with mortality in younger participants (HR = 0.99 [0.85, 1.15] p = .93) and was protective in older participants (HR = 0.87 [0.85, 0.90] p < .001). Hypertension was associated with mortality in younger IF participants (HR = 1.54 [1.30, 1.82] p < .001) but not in older IF participants (HR = 0.99 [0.87, 1.14] p = .93). CONCLUSIONS: Compared with younger and well-functioning persons, the additional contribution of blood pressure to mortality is much lower with older age and impaired function, particularly if both are present. Functional status and age could potentially inform optimal blood pressure targets.
BACKGROUND: Impaired functional status attenuates the relationship of systolic blood pressure (SBP) with mortality in older adults but has not been studied in middle-aged populations. METHOD: Among 10,264 stroke-free Atherosclerosis Risk in Communities participants (mean age 62.8 [5.7] years; 6,349 [62%] younger [<65 years]; 5,148 [50%] men; 2,664 [26%] Black), function was defined as good function (GF) for those self-reporting no difficulty performing functional tasks and basic or instrumental tasks of daily living; all others were defined as impaired function (IF). SBP categories were normal (<120 mmHg), prehypertension (120-139 mmHg), and hypertension (≥140 mmHg). Mortality risk associated with SBP was estimated using adjusted Cox proportional hazard models with a triple interaction between age, functional status, and SBP. RESULTS: Mean follow-up was 12.9 years with 2,863 (28%) deaths. Among younger participants, 3,017 (48%) had IF; 2,279 of 3,915 (58%) older participants had IF. Prehypertension (hazard ratio [HR] = 1.48 [1.03, 2.15] p = .04) and hypertension (HR = 1.97 [1.29, 3.03] p = .002) were associated with mortality in younger GF and older (≥65 years) GF participants (prehypertension HR = 1.21 [1.06, 1.37] p = .005; hypertension HR = 1.47 [1.36, 1.59] p < .001). Among IF participants, prehypertension was not associated with mortality in younger participants (HR = 0.99 [0.85, 1.15] p = .93) and was protective in older participants (HR = 0.87 [0.85, 0.90] p < .001). Hypertension was associated with mortality in younger IF participants (HR = 1.54 [1.30, 1.82] p < .001) but not in older IF participants (HR = 0.99 [0.87, 1.14] p = .93). CONCLUSIONS: Compared with younger and well-functioning persons, the additional contribution of blood pressure to mortality is much lower with older age and impaired function, particularly if both are present. Functional status and age could potentially inform optimal blood pressure targets.
Authors: Nicholas M Pajewski; Jeff D Williamson; William B Applegate; Dan R Berlowitz; Linda P Bolin; Glenn M Chertow; Marie A Krousel-Wood; Nieves Lopez-Barrera; James R Powell; Christianne L Roumie; Carolyn Still; Kaycee M Sink; Rocky Tang; Clinton B Wright; Mark A Supiano Journal: J Gerontol A Biol Sci Med Sci Date: 2016-01-11 Impact factor: 6.053
Authors: Anna M Kucharska-Newton; Priya Palta; Sheila Burgard; Michael E Griswold; Jennifer L Lund; Benjamin D Capistrant; Stephen B Kritchevsky; Karen Bandeen-Roche; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Megan M Marron; Jatinder Singh; Robert M Boudreau; Kaare Christensen; Stephanie Cosentino; Mary F Feitosa; Ryan L Minster; Thomas Perls; Nicole Schupf; Paola Sebastiani; Svetlana Ukraintseva; Mary K Wojczynski; Anne B Newman Journal: J Hypertens Date: 2018-01 Impact factor: 4.844
Authors: Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski Journal: JAMA Date: 2016-06-28 Impact factor: 56.272
Authors: Felicia C Goldstein; Ihab M Hajjar; Callie B Dunn; Allan I Levey; Whitney Wharton Journal: J Gerontol A Biol Sci Med Sci Date: 2016-09-27 Impact factor: 6.053
Authors: Orna Reges; Hongyan Ning; John T Wilkins; Colin O Wu; Xin Tian; Michael J Domanski; Donald M Lloyd-Jones; Norrina B Allen Journal: Hypertension Date: 2020-12-21 Impact factor: 10.190
Authors: Paulina Kaiser; Carmen A Peralta; Richard Kronmal; Michael G Shlipak; Bruce M Psaty; Michelle C Odden Journal: BMJ Open Date: 2018-02-23 Impact factor: 2.692